Upsher-Smith Laboratories announced the launch of Vigadrone (vigabatrin) for Oral Solution, 500 mg, a fully substitutable, AA-rated generic version of Sabril (vigabatrin) powder for oral solution. The product was approved by the U.S. Food and Drug Administration (FDA) on June 21, 2018.
Epicor Software Corp.
CVS Health submitted its comments in response to the Request for Information (RFI) on the Trump Administration’s Blueprint to Lower Drug Prices.
ARLINGTON, Va. – A National Association of Chain Drug Stores ) op-ed published by Morning Consult today describes the role of community pharmacy practice and of NACDS members’ philanthropic initiatives in helping to prevent and manage diabetes.
Pharmaceutical Care Management Association (PCMA) president and chief executive officer Mark Merritt released the following statement today on the Administration’s Blueprint on drug pricing: “We are encouraged that the Administration’s Blueprint raises several proposals that would increase the use o
The American Association of Homeopathic Pharmacists (AAHP) mourns the loss of an industry legend. John (Jack) Borneman, III, grandson of one of the founding members of AAHP, passed away on July 9, 2018.
Amazon rocked the pharmacy world in a big way last month with the announcement of its estimated $1 billion acquisition of PillPack, a 5-year-old company that made a name for itself with pre-sorted medication dose packaging delivered directly to patients’ homes.
Reducing drug costs borne by seniors due to middlemen and deals in the drug supply chain are Medicare Part D reforms that most strongly curry favor among registered voters, according to a Morning Consult survey commissioned by the National Community Pharmacists Association (NCPA).
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) RxIMPACT grassroots advocacy program has mobilized to support a U.S. Senate initiative urging action by U.S.
CVS Health announced today that the CVS Health Foundation will award $330,000 in grants to community health centers in California focused on increasing access to opioid addiction treatment and recovery services.
OXNARD, Calif. – Cure Pharmaceutical announced that it has signed a term sheet with Therapix Biosciences, a specialty, clinical-stage pharmaceutical company developing cannabinoid-based treatments, to acquire the non-pain assets of Therapix, subject to the completion of the related conditions.
As part of CVS Health’s national commitment to address and prevent opioid abuse and misuse, the company has installed 19 safe medication disposal units in CVS Pharmacy locations across Maryland and the CVS Health Foundation has provided $85,000 to Total Health Care in Baltimore, a community health c
Dr. Reddy’s Laboratories announced the launch of hydroxychloroquine sulfate tablets USP, 200 mg, a therapeutic equivalent generic version of Plaquenil (hydroxychloroquine sulfate) tablets, in the U.S. market, approved by the U.S. Food and Drug Administration. The Plaquenil brand and generic had U.S.
A new report makes a compelling, evidence-based case for expanding the role of pharmacy technicians to enhance pharmacist-provided patient care.
Avella Specialty Pharmacy’s Use of AdhereTech smart pill bottles improved adherence and generated one to two additional fills per patient per year across multiple specialty medications and diseases The specialty pharmacy uses the smart bottles for five specialty medications, in programs with four di
